Works matching IS 1758-8340 AND DT 2025

Results: 106
    1

    Frequency of driver oncogenic alterations in NSCLC and estimated indoor radon exposure in Europe (RADON EUROPE study).

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251351449
    By:
    • García-Pardo, Miguel;
    • García de Herreros, Marta;
    • Auclin, Edouard;
    • Ferriol-Galmes, Miquel;
    • Laguna, Juan Carlos;
    • Gorría, Teresa;
    • Caravaca, Gerard;
    • Sart, Joan;
    • Albarrán-Artahona, Víctor;
    • López-Castro, Rafael;
    • Teixidó, Cristina;
    • Castellano, Giancarlo;
    • Martínez Bedmar, Alex;
    • Arcocha, Ainara;
    • Alcolea, Laura;
    • Jiménez, Manuel;
    • Bernabeu, Mario;
    • Delgado-Cano, David;
    • Navarro, Alejandro;
    • Prat, Aleix
    Publication type:
    Article
    2
    3

    Peritoneum carcinomatosis as a favourable prognostic factor for treatment with nanoliposomal irinotecan and fluorouracil plus leucovorin in advanced pancreatic cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251351540
    By:
    • Kobayashi, Satoshi;
    • Fukushima, Taito;
    • Tezuka, Shun;
    • Shiraishi, Kazumasa;
    • Enomoto, Masato;
    • Tsunoda, Shotaro;
    • Hamaguchi, Tomomi;
    • Ohishi, Ritsuko;
    • Tozuka, Yuichiro;
    • Murakawa, Masaaki;
    • Yamamoto, Naoto;
    • Ueno, Makoto;
    • Furuse, Junji;
    • Maeda, Shin
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    Ramucirumab and erlotinib combination as first-line treatment for advanced or recurrent non-small cell lung cancer harboring EGFR Exon21 L858R mutation: a multicenter retrospective observational cohort study in Japan (REAL-SPEED).

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251344010
    By:
    • Ishihara, Masashi;
    • Kawamura, Takahisa;
    • Namba, Yukiko;
    • Takeyasu, Yuki;
    • Hasegawa, Yukihiro;
    • Sato, Yuki;
    • Negi, Yoshiki;
    • Oba, Tomohiro;
    • Sumi, Toshiyuki;
    • Hirata, Hirokuni;
    • Funabashi, Hidemitsu;
    • Oya, Yuko;
    • Kikuchi, Hajime;
    • Katsurada, Naoko;
    • Nakatani, Takeshi;
    • Tanimura, Keiko;
    • Nakagawa, Taku;
    • Takeda, Naoya;
    • Asami, Takahiro;
    • Honjo, Osamu
    Publication type:
    Article
    12
    13
    14

    Proceedings of the seventh annual Women in Melanoma Conference.

    Published in:
    2025
    By:
    • Najjar, Yana G.;
    • Orloff, Marlana;
    • Mitchell, Tara C.;
    • Bowles, Tawnya L.;
    • Betof Warner, Allison;
    • Bollin, Kathryn;
    • Chandra, Sunandana;
    • Cohen, Justine V.;
    • Eroglu, Zeynep;
    • Funchain, Pauline;
    • Gaughan, Elizabeth;
    • Glitza Oliva, Isabella;
    • Hsu, Sherry;
    • Hu-Lieskovan, Siwen;
    • Kennedy, Lucy Boyce;
    • Truong, Thach-Giao;
    • McKean, Meredith;
    • Mehnert, Janice;
    • Moon, Helen;
    • Tsai, Katy K.
    Publication type:
    Editorial
    15
    16

    Impact of low hormone receptor expression on neoadjuvant chemotherapy response and patterns of care in non-metastatic HER2-negative breast cancer: a US National Cancer Database analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251342874
    By:
    • Quiroga, Dionisia;
    • Pei, Charles;
    • Stephens, Julie A.;
    • Johnson, Kai C. C.;
    • Williams, Nicole;
    • Sudheendra, Preeti;
    • Cherian, Mathew;
    • Stover, Daniel;
    • Davenport, Ashley;
    • Gatti-Mays, Margaret;
    • Wesolowski, Robert;
    • Bazan, Jose G.;
    • Beyer, Sasha;
    • Park, Ko Un;
    • Oppong, Bridget A.;
    • White, Julia;
    • Jhawar, Sachin R.;
    • Sardesai, Sagar
    Publication type:
    Article
    17

    NEXUS: a phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251339930
    By:
    • R. Choo, Joan;
    • Jeraj, Santhiay Nathan;
    • Sundar, Raghav;
    • Yong, Wei Peng;
    • Lee, Matilda;
    • Huang, Yiqing;
    • Asokumaran, Yugarajah;
    • Chan, Gloria H. J.;
    • Ngoi, Natalie Y. L.;
    • Wong, Andrea L. A.;
    • Soo, Ross A.;
    • Chee, Cheng Ean;
    • Lim, Joline S. J.;
    • Goh, Boon Cher;
    • Lee, Soo Chin;
    • Tan, David S. P.
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25
    26

    Efficacy and safety of distinct regimens for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review and network meta-analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251338046
    By:
    • Zhang, Wengang;
    • Xiong, Jian;
    • Li, Yujie;
    • Nie, Jing;
    • Zhao, Wencheng;
    • Guo, Zhiyi;
    • Liu, Xinyue;
    • Zhang, Qianqian;
    • Chen, Xuyang;
    • Ye, Li;
    • Chen, Zhimin;
    • Wang, Hao;
    • Xu, Kandi;
    • Zhao, Lishu;
    • Liu, Yujin;
    • Huang, Lihua;
    • Li, Yuhang;
    • He, Yayi
    Publication type:
    Article
    27

    Patterns of SARS-CoV-2-specific humoral and cellular immune response in actively treated patients with solid cancer following prime BNT162b2 COVID-19 vaccination: results from phase IV CoVigi trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251316224
    By:
    • Obermannova, Radka Lordick;
    • Selingerova, Iveta;
    • Demlova, Regina;
    • Okruhlicova, Dominika;
    • Nevrlka, Jiri;
    • Cerna-Pilatova, Katerina;
    • Greplova, Kristina;
    • Cermakova, Zdenka;
    • Valik, Dalibor;
    • Kiss, Igor;
    • Palacova, Marketa;
    • Poprach, Alexandr;
    • Lejdarova, Hana;
    • Selvekerova, Sarka;
    • Vaneckova, Martina;
    • Zdrazilova-Dubska, Lenka
    Publication type:
    Article
    28
    29
    30
    31

    Impact of CD44/326 peritoneal cells as response indicators in advanced gastric cancer patients receiving repeated intraperitoneal perfusion normothermic chemotherapy.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251337480
    By:
    • Filho, Odilon de Souza;
    • Rondinelli, Reinaldo;
    • Acetta, Antônio Carlos;
    • Bertolace, Sérgio;
    • Palladino, Alexandre;
    • Guedes, Cristiano Duque;
    • Vieira, Claudia Cristine Rocha;
    • Thuler, Luis Claudio Santos;
    • Diniz, Claudia;
    • dos Santos, Everton Cruz;
    • Abdelhay, Eliana
    Publication type:
    Article
    32
    33
    34

    Comparison of immune checkpoint inhibitors in combination with chemotherapy versus chemotherapy alone in the first-line treatment of advanced gastric cancer patients with low PD-L1 expression: a systematic review and meta-analysis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251336627
    By:
    • Wang, Yuxin;
    • Xie, Tong;
    • Xiang, Shuai;
    • Liu, Cheng;
    • Cheng, Siyuan;
    • Zhang, Bohan;
    • Zhang, Yifan;
    • Feng, Yang;
    • Wang, Yingxuan;
    • Yu, Donghe;
    • Gao, Hongchao;
    • Gao, Erke;
    • Shen, Lin;
    • Peng, Zhi
    Publication type:
    Article
    35

    Xevinapant plus avelumab in advanced solid tumours, with a dose expansion in advanced non-small-cell lung cancer: exploratory biomarker, safety and efficacy analyses from an open-label, nonrandomised phase Ib study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251332154
    By:
    • Goss, Glenwood;
    • Ciuleanu, Tudor;
    • Ramlau, Rodryg;
    • Renouf, Daniel J.;
    • Chu, Quincy;
    • Kalinka, Ewa;
    • Sawrycki, Piotr;
    • Bramson, Jonathan;
    • Nelson, Brad H.;
    • Crabbé, Rafael;
    • LaCasse, Eric;
    • Lo, Bryan;
    • Sahlender, Daniela A.;
    • Crompton, Philippa;
    • Brichory, Franck;
    • Piggott, Luke;
    • Schenker, Michael;
    • Juergens, Rosalyn
    Publication type:
    Article
    36
    37
    38
    39
    40
    41
    42

    TROPION-Breast05: a randomized phase III study of Dato-DXd with or without durvalumab versus chemotherapy plus pembrolizumab in patients with PD-L1-high locally recurrent inoperable or metastatic triple-negative breast cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251327992
    By:
    • Schmid, Peter;
    • Oliveira, Mafalda;
    • O'Shaughnessy, Joyce;
    • Cristofanilli, Massimo;
    • Graff, Stephanie L.;
    • Im, Seock-Ah;
    • Loi, Sherene;
    • Saji, Shigehira;
    • Wang, Shusen;
    • Cescon, David W.;
    • Hovey, Tina;
    • Nawrot, Agata;
    • Tse, Karson;
    • Vukovic, Petra;
    • Curigliano, Giuseppe
    Publication type:
    Article
    43

    Navigating second-line therapy in metastatic renal cell carcinoma: a comparative analysis of immune checkpoint inhibitors and tyrosine kinase inhibitors: a study of Turkish Oncology Group Kidney Cancer Consortium.

    Published in:
    Therapeutic Advances in Medical Oncology, 2025, p. 1, doi. 10.1177/17588359251331540
    By:
    • Aykan, Musa Barış;
    • Bölek, Hatice;
    • Yekedüz, Emre;
    • Sertesen, Elif;
    • Tural, Deniz;
    • Karaçin, Cengiz;
    • Şendur, Mehmet Ali Nahit;
    • Uçar, Gökhan;
    • Arslan, Çağatay;
    • Işık, Selver;
    • Sim, Saadet;
    • Sever, Özlem Nuray;
    • Hacıoğlu, Bekir;
    • Sezgin Göksu, Sema;
    • Özgüroğlu, Mustafa;
    • Karadurmuş, Nuri;
    • Ürün, Yüksel
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50